Dyne Therapeutics, Inc.
DYNNASDAQHealthcare● Active
$16.81
$-0.23(-1.35%)
Market Cap$2.8B
P/E Ratio—
52W High$25
52W Low$8.06
Dyne Therapeutics, Inc. (DYN) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DYN · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.45B) | ($0.32B) | ($0.24B) | ($0.17B) | ($0.15B) |
| Depreciation & Amort. | $0.00B | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.05B | $0.05B | $0.02B | $0.02B | $0.02B |
| Change in Working Capital | ($0.00B) | ($0.02B) | $0.03B | ($0.01B) | $0.01B |
| Net Cash from Operations | ($0.40B) | ($0.29B) | ($0.19B) | ($0.15B) | ($0.12B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.18B) | ($0.32B) | ($0.04B) | ($0.12B) | ($0.24B) |
| Sales of Investments | $0.17B | $0.12B | $0.13B | $0.21B | $0.10B |
| Net Cash from Investing | ($0.03B) | ($0.20B) | $0.08B | $0.09B | ($0.14B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.15B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.89B | $0.81B | $0.05B | $0.04B | $0.16B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.41B) | ($0.29B) | ($0.19B) | ($0.16B) | ($0.12B) |
| FCF Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Dyne Therapeutics, Inc. data
About Dyne Therapeutics, Inc. (DYN) Cash Flow Statement
Dyne Therapeutics, Inc. generated operating cash flow of ($0.40B) and free cash flow of ($0.41B) for 2025 — a FCF margin of —. Capital expenditure was ($0.00B).
Frequently asked questions
DYN · 4 questionsDyne Therapeutics, Inc. generated free cash flow of ($0.41B) for 2025, down 37.4% year-over-year.
DYN free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10